Primodos patients ‘betrayed’ after being left out of health scandals redress report

Posted on February 7, 2024 by Admin

Families who may have been affected by hormone pregnancy tests not included in patient safety commissioner’s review

Campaigners have accused the UK government of betraying them after a review of redress for victims of health scandals excluded families who may have been affected by the hormone pregnancy test Primodos.

A report published on Wednesday by the patient safety commissioner, Dr Henrietta Hughes, found a “clear case for redress” for thousands of women and children who suffered “avoidable harm” from the epilepsy treatment sodium valproate and from vaginal mesh implants.

Denial of women’s concerns contributed to medical scandals, says inquiry

Posted on July 7, 2020 by Admin

Review into vaginal mesh and other products reveals much patient harm was ‘avoidable’

An arrogant culture in which serious medical complications were dismissed as “women’s problems” contributed to a string of healthcare scandals over several decades, an inquiry ordered by the government has found.

The review of vaginal mesh, hormonal pregnancy tests and an anti-epilepsy medicine that harmed unborn babies paints a damning picture of a medical establishment that failed to acknowledge problems even in the face of mounting safety concerns, leading to avoidable harm to patients.

Johnson & Johnson ordered to pay $2.6m in damages over vaginal mesh implants

Posted on March 3, 2020 by Admin

Federal court orders pharmaceutical giant to pay costs and damages to three lead applicants in Australian class action

Pharmaceutical giant Johnson & Johnson has been ordered by the federal court to pay out almost $2.6m in damages to three women who received faulty pelvic mesh implants.

Justice Anna Katzmann last year ruled that Johnson & Johnson and two subsidiaries had acted negligently over the defective vaginal implants that left hundreds in debilitating pain.

Australian women win landmark vaginal mesh class action against Johnson & Johnson

Posted on November 20, 2019 by Admin

The case was launched on behalf of 700 women who had pelvic mesh and tape products implanted to treat common complications of childbirth

Hundreds of women left in debilitating pain by faulty transvaginal mesh devices have won a landmark case against multinational giant Johnson & Johnson.

The Australian class action against companies owned by Johnson & Johnson – watched closely across the world – was won on behalf of 1,350 women who had mesh and tape products implanted to treat pelvic prolapse or stress urinary incontinence, both common complications of childbirth.